Found 0 matching trials
Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females PHASE2 Evaluate immunogenicity and safety of recombinant human papillomavirus biva...
Show More Location
GuangXi Center for Diseases Control and Prevention
Learn More & Join Trial
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female N/A The primary objective of this study is to evaluate the durability of protec...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial PHASE3 A 3-dose HPV vaccination scheme has shown to be safe and immunogenic in peo...
Show More Location
Multiple Locations
Learn More & Join Trial
Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial PHASE4 This phase IV trial tests whether a single dose of the human papillomavirus...
Show More Status
Active Not Recruiting
Location
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Learn More & Join Trial
Intradermal, Fractional Dose of HPV Vaccines: PHASE4 This randomized phase IV trial compares fractional dose of bivalent HPV vac...
Show More Status
Active Not Recruiting
Location
University of Washington Virology Research Clinic
Learn More & Join Trial
The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine PHASE4 The purpose of this study is to evaluate the immunogenicity and safety of R...
Show More Location
Yuecheng Center for Disease Control and Prevention
Learn More & Join Trial
The KEN SHE Study on HPV-vaccine Efficacy PHASE4 The KEN SHE Study aims to identify effective cervical cancer prevention str...
Show More Location
Partners in Health, Research and Development
Learn More & Join Trial
Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®) PHASE4 Six identical female twins aged 9-13 years will participate. One sib of eac...
Show More Location
Ghent University Hospital
Learn More & Join Trial
Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years PHASE4 This study aims to assess the immunogenicity and safety of a sequential 2vh...
Show More Status
Active Not Recruiting
Location
Jinyun center for Disease Control and Prevention
Learn More & Join Trial
Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine PHASE1 This phase I clinical study was designed to evaluate the safety of novel re...
Show More Location
Jiangsu Provincial Centre for Disease Control and Prevention
Learn More & Join Trial